Business Standard

Russia eyeing partnership with India to produce Covid-19 vaccine Sputnik V

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF

covid, coronavirus, vaccine, drug, pharma
Premium

The vaccine has not been tested in Phase 3 or larger clinical trials

Press Trust of India New Delhi
Russia is looking for a partnership with India for producing Covid-19 vaccine Sputnik V, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), said on Thursday.
 
Russian President Vladimir Putin had announced that his country has developed the world's first vaccine against Covid-19, which works "quite effectively" and forms a "stable immunity" against the disease.
 
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. The vaccine has not been tested in Phase 3 or larger clinical trials.
 
Addressing an online press briefing, Dmitriev said several nations are interested in

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in